3 Insider-Owned Growth Stocks To Watch

In This Article:

In the wake of a historic U.S. election, global markets have shown robust performance, with major indices like the S&P 500 and Nasdaq Composite reaching record highs amid expectations of favorable economic policies. This optimistic climate highlights the potential for growth stocks, particularly those with high insider ownership, as they often reflect strong confidence in a company's future prospects from those who know it best.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Medley (TSE:4480)

34%

30.4%

Pharma Mar (BME:PHM)

11.8%

56.4%

Findi (ASX:FND)

34.8%

64.8%

Credo Technology Group Holding (NasdaqGS:CRDO)

13.9%

95%

Alkami Technology (NasdaqGS:ALKT)

11.2%

98.6%

Adveritas (ASX:AV1)

21.2%

144.2%

Plenti Group (ASX:PLT)

12.8%

107.6%

EHang Holdings (NasdaqGM:EH)

32.8%

81.4%

Brightstar Resources (ASX:BTR)

14.8%

84.6%

UTI (KOSDAQ:A179900)

33.1%

134.6%

Click here to see the full list of 1529 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Dollar Industries

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Dollar Industries Limited manufactures and sells hosiery products, including knitted innerwear, casual wear, and thermal wear in India and internationally, with a market cap of ₹31 billion.

Operations: The company's revenue primarily comes from garments, hosiery goods, rainwear products, and related services, totaling ₹15.78 billion.

Insider Ownership: 14.2%

Revenue Growth Forecast: 12.5% p.a.

Dollar Industries demonstrates promising growth potential with forecasted earnings growth of 30.6% annually, outpacing the Indian market's 18%. The company's revenue is expected to grow at 12.5% per year, faster than the market average but below significant thresholds. Recent earnings showed improvement with net income rising to INR 153.03 million from INR 145.26 million a year ago. However, its dividend yield of 0.56% is not well covered by free cash flows, and debt coverage by operating cash flow remains inadequate.

NSEI:DOLLAR Earnings and Revenue Growth as at Nov 2024
NSEI:DOLLAR Earnings and Revenue Growth as at Nov 2024

Entero Healthcare Solutions

Simply Wall St Growth Rating: ★★★★★☆

Overview: Entero Healthcare Solutions Limited is involved in the trading of pharmaceutical and surgical products to various healthcare providers in India, with a market cap of ₹65.40 billion.

Operations: The company's revenue is primarily derived from trading pharmaceutical and surgical products, amounting to ₹41.32 billion.